| Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis G Lassailly, R Caiazzo, LC Ntandja-Wandji, V Gnemmi, G Baud, ... Gastroenterology 159 (4), 1290-1301. e5, 2020 | 392 | 2020 |
| The role of telomeres and telomerase in cirrhosis and liver cancer JC Nault, M Ningarhari, S Rebouissou, J Zucman-Rossi Nature Reviews Gastroenterology & Hepatology 16 (9), 544-558, 2019 | 200 | 2019 |
| Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target M Ningarhari, S Caruso, TZ Hirsch, Q Bayard, A Franconi, AL Védie, ... Journal of Hepatology 74 (5), 1155-1166, 2021 | 71 | 2021 |
| Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study E Trépo, S Caruso, J Yang, S Imbeaud, G Couchy, Q Bayard, E Letouzé, ... The Lancet Oncology 23 (1), 161-171, 2022 | 52 | 2022 |
| IL-33/ST2 pathway regulates neutrophil migration and predicts outcome in patients with severe alcoholic hepatitis F Artru, MB Saleh, F Maggiotto, G Lassailly, M Ningarhari, J Demaret, ... Journal of Hepatology 72 (6), 1052-1061, 2020 | 41 | 2020 |
| Loss of hepatocyte identity following aberrant YAP activation: a key mechanism in alcoholic hepatitis MB Saleh, A Louvet, LC Ntandja-Wandji, E Boleslawski, V Gnemmi, ... Journal of hepatology 75 (4), 912-923, 2021 | 40 | 2021 |
| Nucleotide-binding oligomerization domain 1 (NOD1) modulates liver ischemia reperfusion through the expression adhesion molecules G Lassailly, MB Saleh, N Leleu-Chavain, M Ningarhari, É Gantier, ... Journal of hepatology 70 (6), 1159-1169, 2019 | 22 | 2019 |
| Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study Q Zeng, C Klein, S Caruso, P Maille, DS Allende, B Mínguez, M Iavarone, ... The Lancet Oncology 24 (12), 1411-1422, 2023 | 17 | 2023 |
| Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma J Calderaro, L Di Tommaso, P Maillé, A Beaufrère, CT Nguyen, L Heij, ... Journal of hepatology 77 (6), 1586-1597, 2022 | 15 | 2022 |
| Systemic treatments with tyrosine kinase inhibitor and platinum-based chemotherapy in patients with unresectable or metastatic hepatocholangiocarcinoma E Gigante, C Hobeika, B Le Bail, V Paradis, D Tougeron, M Lequoy, ... Liver Cancer 11 (5), 460-473, 2022 | 14 | 2022 |
| Management of alcohol‐related liver disease: the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines A Louvet, JB Trabut, C Moreno, R Moirand, HJ Aubin, LC Ntandja Wandji, ... Liver International 42 (6), 1330-1343, 2022 | 12 | 2022 |
| Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma J Calderaro, N Ghaffari Laleh, Q Zeng, P Maille, L Favre, A Pujals, C Klein, ... Nature communications 14 (1), 8290, 2023 | 8 | 2023 |
| Morbid obesity increases death and dropout from the liver transplantation waiting list: A prospective cohort study C Delacôte, M Favre, M El Amrani, M Ningarhari, E Lemaitre, ... United European Gastroenterology Journal 10 (4), 396-408, 2022 | 7 | 2022 |
| Real life experience of mycophenolate mofetil monotherapy in liver transplant patients G Lassailly, J Dumortier, F Saint-Marcoux, M El Amrani, J Boulanger, ... Clinics and Research in Hepatology and Gastroenterology 45 (1), 101451, 2021 | 6 | 2021 |
| Transcatheter aortic valve replacement (TAVR) as bridge therapy restoring eligibility for liver transplantation in cirrhotic patients C Levy, G Lassailly, M El Amrani, F Vincent, C Delhaye, T Meurice, ... American Journal of Transplantation 20 (9), 2567-2570, 2020 | 6 | 2020 |
| Lung infection affects access to treatment and short-term outcome in patients with severe alcohol-related hepatitis treated with corticosteroids LCN Wandji, M Ningarhari, E Lemaître, M Khaldi, P Saffers, J Lollivier, ... Official journal of the American College of Gastroenterology| ACG 117 (7 …, 2022 | 5 | 2022 |
| Tumor heterogeneity and resistance to targeted therapies in hepatocellular carcinoma AJ Craig, I Labgaa, C Villacorta-Martin, M Ningarhari, A Villanueva Resistance to Molecular Therapies for Hepatocellular Carcinoma, 1-24, 2017 | 5 | 2017 |
| Liver transplantation in alcohol-related liver disease and alcohol-related hepatitis LCN Wandji, M Ningarhari, G Lassailly, S Dharancy, E Boleslawski, ... Journal of Clinical and Experimental Hepatology 13 (1), 127-138, 2023 | 4 | 2023 |
| Neo-adjuvant use of sorafenib for hepatocellular carcinoma awaiting liver transplantation K Minoux, G Lassailly, M Ningarhari, H Lubret, M El Amrani, V Canva, ... Transplant International 35, 10569, 2022 | 3 | 2022 |
| Regression of Fibrosis after Disappearance of Nash in Morbidly Obese Patients: A Prospective Bariatric Surgery Cohort with Sequential Liver Biopsies. G Lassailly, R Caiazzo, V Gnemmi, A Louvet, E Leteutre, F Artru, ... Hepatology 68, 44A, 2018 | 3 | 2018 |
